Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin
- PMID: 19462418
- PMCID: PMC2757082
- DOI: 10.1002/bip.21262
Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin
Abstract
The mitochondrial F(1)F(o)-ATPase performs the terminal step of oxidative phosphorylation. Small molecules that modulate this enzyme have been invaluable in helping decipher F(1)F(o)-ATPase structure, function, and mechanism. Aurovertin is an antibiotic that binds to the beta subunits in the F(1) domain and inhibits F(1)F(o)-ATPase-catalyzed ATP synthesis in preference to ATP hydrolysis. Despite extensive study and the existence of crystallographic data, the molecular basis of the differential inhibition and kinetic mechanism of inhibition of ATP synthesis by aurovertin has not been resolved. To address these questions, we conducted a series of experiments in both bovine heart mitochondria and E. coli membrane F(1)F(o)-ATPase. Aurovertin is a mixed, noncompetitive inhibitor of both ATP hydrolysis and synthesis with lower K(i) values for synthesis. At low substrate concentrations, inhibition is cooperative suggesting a stoichiometry of two aurovertin per F(1)F(o)-ATPase. Furthermore, aurovertin does not completely inhibit the ATP hydrolytic activity at saturating concentrations. Single-molecule experiments provide evidence that the residual rate of ATP hydrolysis seen in the presence of saturating concentrations of aurovertin results from a decrease in the binding change mechanism by hindering catalytic site interactions. The results from these studies should further the understanding of how the F(1)F(o)-ATPase catalyzes ATP synthesis and hydrolysis.
(c) 2009 Wiley Periodicals, Inc. Biopolymers 91: 830-840, 2009.
Figures









Similar articles
-
The native mitochondrial F1-inhibitor protein complex carries out uni- and multisite ATP hydrolysis.J Biol Chem. 1990 Nov 5;265(31):19002-6. J Biol Chem. 1990. PMID: 2146268
-
Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity.Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1747-55. doi: 10.1152/ajpheart.01019.2003. Am J Physiol Heart Circ Physiol. 2004. PMID: 15371268
-
Epsilon subunit of Escherichia coli F1-ATPase: effects on affinity for aurovertin and inhibition of product release in unisite ATP hydrolysis.Biochemistry. 1987 Jul 14;26(14):4488-93. doi: 10.1021/bi00388a047. Biochemistry. 1987. PMID: 2889464
-
Antibiotic inhibitors of mitochondrial ATP synthesis.Fed Proc. 1975 Jul;34(8):1707-10. Fed Proc. 1975. PMID: 124269 Review.
-
Energetic signalling in the control of mitochondrial F1F0 ATP synthase activity in health and disease.Int J Biochem Cell Biol. 2008;40(12):2698-701. doi: 10.1016/j.biocel.2008.06.013. Epub 2008 Jul 30. Int J Biochem Cell Biol. 2008. PMID: 18707016 Review.
Cited by
-
Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.Br J Pharmacol. 2012 Aug;166(8):2331-47. doi: 10.1111/j.1476-5381.2012.01958.x. Br J Pharmacol. 2012. PMID: 22452346 Free PMC article.
-
Dynamic ligand-induced conformational rearrangements in P-glycoprotein as probed by fluorescence resonance energy transfer spectroscopy.J Biol Chem. 2012 Jan 6;287(2):1112-27. doi: 10.1074/jbc.M111.301192. Epub 2011 Nov 15. J Biol Chem. 2012. PMID: 22086917 Free PMC article.
-
Fluoride resistance in Streptococcus mutans: a mini review.J Oral Microbiol. 2017 Jul 6;9(1):1344509. doi: 10.1080/20002297.2017.1344509. eCollection 2017. J Oral Microbiol. 2017. PMID: 28748043 Free PMC article. Review.
-
Twisting and subunit rotation in single F(O)(F1)-ATP synthase.Philos Trans R Soc Lond B Biol Sci. 2012 Dec 24;368(1611):20120024. doi: 10.1098/rstb.2012.0024. Print 2013 Feb 5. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 23267178 Free PMC article. Review.
-
Natural products and other inhibitors of F1FO ATP synthase.Eur J Med Chem. 2020 Dec 1;207:112779. doi: 10.1016/j.ejmech.2020.112779. Epub 2020 Sep 3. Eur J Med Chem. 2020. PMID: 32942072 Free PMC article. Review.
References
-
- Linnett PE, Beechey RB. Methods Enzymol. 1979;55:472–518. - PubMed
-
- Lardy HA, Connelly JL, Johnson D. Biochemistry. 1964;3:1961–1968. - PubMed
-
- Verschoor GJ, van der Sluis PR, Slater EC. Biochim Biophys Acta. 1977;462:438–449. - PubMed
-
- Douglas MG, Koh Y, Dockter ME, Schatz G. J Biol Chem. 1977;252:8333–8335. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical